Department of Anesthesiology, Division of Critical Care Medicine, University of Minnesota, Minneapolis, MN; Department of Anesthesiology, Division of Critical Care Medicine, Emory School of Medicine, Atlanta, GA.
Department of Anesthesiology, Cedars-Sinai Medical Center, Los Angeles, CA.
J Cardiothorac Vasc Anesth. 2024 Oct;38(10):2238-2246. doi: 10.1053/j.jvca.2024.06.021. Epub 2024 Jun 19.
OBJECTIVE(S): Acute kidney injury (AKI) is defined and staged by reduced urine output (UO) and increased serum creatinine (SCr). UO is typically measured manually and documented in the electronic health record, making early and reliable detection of oliguria-based AKI and electronic data extraction challenging. The authors investigated the diagnostic performance of continuous UO, enabled by active drain line clearance-based alerts (Accuryn AKI Alert), compared with AKI stage 2 SCr criteria and their associations with length of stay, need for continuous renal replacement therapy, and 30-day mortality.
This study was a prospective and retrospective observational study.
Nine tertiary centers participated.
Cardiac surgery patients were enrolled.
None.
A total of 522 patients were analyzed. AKI stages 1, 2, and 3 were diagnosed in 32.18%, 30.46%, and 3.64% of patients based on UO, compared with 33.72%, 4.60%, and 3.26% of patients using SCr, respectively. Continuous UO-based alerts diagnosed stage ≥1 AKI 33.6 (IQR =15.43, 95.68) hours before stage ≥2 identified by SCr criteria. A SCr-based diagnosis of AKI stage ≥2 has been designated a Hospital Harm by the Centers for Medicare & Medicaid Services. Using this criterion as a benchmark, AKI alerts had a discriminative power of 0.78. The AKI Alert for stage 1 was significantly associated with increased intensive care unit and hospital length of stay and continuous renal replacement therapy, and stage ≥2 alerts were associated with mortality.
AKI Alert, based on continuous UO and enabled by active drain line clearance, detected AKI stages 1 and 2 before SCr criteria. Early AKI detection allows for early kidney optimization, potentially improving patient outcomes.
急性肾损伤(AKI)的定义和分期依据是尿量减少(UO)和血清肌酐(SCr)升高。UO 通常通过手动测量并记录在电子健康记录中,这使得基于少尿的 AKI 的早期和可靠检测以及电子数据提取具有挑战性。作者研究了基于主动引流线清除的连续 UO 的诊断性能(Accuryn AKI Alert),与 AKI 第 2 期 SCr 标准及其与住院时间、持续肾脏替代治疗的需求和 30 天死亡率的关系。
本研究为前瞻性和回顾性观察性研究。
9 个三级中心参与。
心脏手术患者被纳入研究。
无。
共分析了 522 名患者。根据 UO,32.18%、30.46%和 3.64%的患者分别诊断为 AKI 第 1、2 和 3 期,而根据 SCr,33.72%、4.60%和 3.26%的患者分别诊断为 AKI 第 1、2 和 3 期。基于连续 UO 的警报在基于 SCr 标准诊断出≥2 期 AKI 前 33.6(IQR=15.43,95.68)小时诊断出≥1 期 AKI。美国医疗保险和医疗补助服务中心将 SCr 诊断的 AKI 第 2 期指定为医院伤害。使用这一标准作为基准,AKI 警报的区分能力为 0.78。AKI 警报第 1 期与重症监护病房和医院住院时间延长以及持续肾脏替代治疗显著相关,而第≥2 期警报与死亡率相关。
基于连续 UO 并通过主动引流线清除实现的 AKI 警报在 SCr 标准之前检测到 AKI 第 1 和 2 期。早期 AKI 检测可以实现早期肾脏优化,可能改善患者结局。